课题基金 / 基金详情

PHASE II RHIL-12 IN MF WITH CROSS-OVER TO PHASE I IL-2 ADMINISTERED WITH IL-12

PHASE II RHIL-12 IN MF WITH CROSS-OVER TO PHASE I IL-2 ADMINISTERED WITH IL-12
MF 中的 II 期 RHIL-12 与 IL-12 联合给药的 I 期 IL-2 交叉
批准号:
7375495
负责人:
GARY S WOOD
金额:
$0.03万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30
关键词:

项目摘要

项目成果

GARY S WOOD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is closed to new enrollment at this site. This clinical trial is testing a new therapy for a type of cancer known as cutaneous T-cell lymphoma. The treatment involves injections of two types of small proteins known as cytokines: interleukin-12 and interleukin-2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of c-CBL Regulation in Cutaneous T-Cell Lymphoma (CTCL)
  • 批准号:
    9242573
  • 项目类别:
  • 资助金额:
    $16.64万
  • 财政年份:
    2016
  • 负责人:
    GARY S WOOD
  • 依托单位:
FAS Pathway Abnormalities in MF and SS
Skin Diseases Research Center at the University of Wisconsin
  • 批准号:
    8738104
  • 项目类别:
  • 资助金额:
    $51.47万
  • 财政年份:
    2014
  • 负责人:
    GARY S WOOD
  • 依托单位:
Skin Diseases Research Center at the University of Wisconsin
  • 批准号:
    9336234
  • 项目类别:
  • 资助金额:
    $34.96万
  • 财政年份:
    2014
  • 负责人:
    GARY S WOOD
  • 依托单位:
国内基金
海外基金
基于生境成像与深度学习联合临床特征构建II型卵巢癌术前淋巴结转移预测模型的研究
鸡软骨非变性II型胶原高效制备和靶向递送的关键技术开发与应用示范
青蒿琥酯协同TROP2/线粒体级联靶向的NIR-II多模态诊疗用于晚期TNBC精准诊断与治疗的机制研究
  • 批准号:
    2026JJ30126
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    杨沙
  • 依托单位:
苏合颗粒治疗慢性萎缩性胃炎的临床(II期)评价关键技术研究